MedPath
NMPA Approval

Lenalidomide Capsules

国药准字HJ20171348

December 7, 2023

H20171348

Drug Information

来那度胺胶囊

瑞复美

胶囊剂

25mg

化学药品

December 7, 2023

December 6, 2028

Company Information

Applicant Company

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

Manufacturing Company

Route de Perreux 1, 2017 Boudry, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.